Articles by Reflector - Pharmaceutical Executive

ADVERTISEMENT

Articles by Reflector

Industry/Gov't R&D Support: So Far So Good

Feb 1, 2012

The EU's Innovative Medicines Initiative is helping to invigorate new drug development, but there are still many hurdles to tackle before its promise is realized.

Here's to a Happier New Year?

Jan 1, 2012

A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.

Europe's Transparency Directive Revisited

Dec 1, 2011

The effect on pharma of the EU's Transparency Directive has been overly constraining, but will the mooted revisions offer any room to maneuver?

Europe in HTA Gridlock

Aug 1, 2011

HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.

Holy Surge of Enthusiasm!

Jul 1, 2011

While Europe's EFPIA preaches about embracing change, much remains to be done to prove the adjustment in philosophy

A Lack of Information

Jun 1, 2011

Why has the EU still not managed to update its rules on information about medicines?

Seeing Through the Transparency Directive

May 1, 2011

The EU is largely powerless when it comes to policies over pricing and reimbursement

Dalli's Formula Fails the Efficacy Test

Apr 1, 2011

EU leadership on pharma policy leaves many wondering of the right man is at the helm

Euro Soul-Searching on Competition

Oct 1, 2010

A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers

ADVERTISEMENT

Click here